Could cytokine levels in the peri-implant crevicular fluid be used to distinguish between healthy implants and implants with peri-implantitis? A systematic review

Journal of Periodontal Research

Volumn 51, Issue 6, 2016, Pages 689-698

  Duarte, P M ^a   Serrao C R ^a   Miranda, T S ^a   Zanatta, L C S ^a   Bastos, M F ^a   Faveri, M ^a   Figueiredo, L C ^a   Feres, M ^a  

^a University of Guarulhos   (Brazil)

Author keywords

chemokines; cytokines; dental implants; peri implantitis

Indexed keywords

CYTOKINE;

ADVERSE DEVICE EFFECT; CHEMISTRY; GINGIVITIS; HUMAN; METABOLISM; PERIIMPLANTITIS; TOOTH IMPLANT;

CYTOKINES; DENTAL IMPLANTS; GINGIVAL CREVICULAR FLUID; HUMANS; PERI-IMPLANTITIS;

EID: 84955121731     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12354     Document Type: Review

References (40)

1. Smeets R, Henningsen A, Jung O, Heiland M, Hammächer C, Stein JM. Definition, etiology, prevention and treatment of peri-implantitis–a review. Head Face Med 2014;10:34.
2. Atieh MA, Alsabeeha NH, Faggion CM Jr, Duncan WJ. The frequency of peri-implant diseases: a systematic review and meta-analysis. J Periodontol 2013;84:1586–1598.
3. Mombelli A, Müller N, Cionca N. The epidemiology of peri-implantitis. Clin Oral Implants Res 2012;23(suppl 6):67–76.
4. Heitz-Mayfield LJ. Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol 2008;35(suppl 8):292–304.
5. Candel-Martí ME, Flichy-Fernández AJ, Alegre-Domingo T, Ata-Ali J, Peñarrocha-Diago MA. Interleukins IL-6, IL-8, IL-10, IL-12 and periimplant disease. An update. Med Oral Patol Oral Cir Bucal 2011;16:e518–e521.
6. Javed F, Al-Hezaimi K, Salameh Z, Almas K, Romanos GE. Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis. Cytokine 2011;53:8–12.
7. Nogueira-Filho G, Xiang XM, Shibli JA et al. On site noninvasive assessment of peri-implant inflammation by optical spectroscopy. J Periodontal Res 2011;46:382–388.
8. Li JY, Wang HL. Biomarkers associated with peri-implant diseases. Implant Dent 2014;23:607–611.
9. Faot F, Nascimento GG, Bielemann AM, Campão TD, Leite FR, Quirynen M. Can peri-implant crevicular fluid assist in the diagnosis of peri-implantitis? A systematic review and meta-analysis. J Periodontol 2015;86:631–645.
10. Renvert S, Widén C, Persson GR. Cytokine expression in peri-implant crevicular fluid in relation to bacterial presence. J Clin Periodontol 2015;42:697–702.
11. Hall J, Pehrson NG, Ekestubbe A, Jemt T, Friberg B. A controlled, cross-sectional exploratory study on markers for the plasminogen system and inflammation in crevicular fluid samples from healthy, mucositis and peri-implantitis sites. Eur J Oral Implantol 2015;8:153–166.
12. Hall J, Britse AO, Jemt T, Friberg B. A controlled clinical exploratory study on genetic markers for peri-implantitis. Eur J Oral Implantol 2011;4:371–382.
13. Xie P, Deng LX, Gong P, Ding Y, Tang XH. Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis. Braz J Microbiol 2011;42:1213–1219.
14. Luo L, Xie P, Gong P, Tang XH, Ding Y, Deng LX. Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis. Arch Oral Biol 2011;56:1106–1111.
15. Petković AB, Matić SM, Stamatović NV et al. Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg 2010;39:478–485.
16. Arikan F, Buduneli N, Kütükçüler N. Osteoprotegerin levels in peri-implant crevicular fluid. Clin Oral Implants Res 2008;19:283–288.
17. Salcetti JM, Moriarty JD, Cooper LF et al. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofac Implants 1997;12:32–42.
18. Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. Int J Oral Maxillofac Implants 1996;11:794–799.
19. Kao RT, Curtis DA, Richards DW, Preble J. Increased interleukin-1 beta in the crevicular fluid of diseased implants. Int J Oral Maxillofac Implants 1995;10:696–701.
20. Aboyoussef H, Carter C, Jandinski JJ, Panagakos FS. Detection of prostaglandin E2 and matrix metalloproteinases in implant crevicular fluid. Int J Oral Maxillofac Implants 1998;13:689–696.
21. Hultin M, Gustafsson A, Hallström H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002;13:349–358.
22. Murata M, Tatsumi J, Kato Y et al. Osteocalcin, deoxypyridinoline and interleukin-1beta in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res 2002;13:637–643.
23. Lachmann S, Kimmerle-Müller E, Axmann D, Scheideler L, Weber H, Haas R. Associations between peri-implant crevicular fluid volume, concentrations of crevicular inflammatory mediators, and composite IL-1A -889 and IL-1B +3954 genotype. A cross-sectional study on implant recall patients with and without clinical signs of peri-implantitis. Clin Oral Implants Res 2007;18:212–223.
24. Duarte PM, de Mendonça AC, Máximo MB, Santos VR, Bastos MF, Nociti FH. Effect of anti-infective mechanical therapy on clinical parameters and cytokine levels in human peri-implant diseases. J Periodontol 2009;80:234–243.
25. Sarlati F, Sattari M, Gazar AG, Rafsenjani AN. Receptor activator of nuclear factor kappa B ligand (RANKL) levels in peri-implant crevicular fluid. Iran J Immunol 2010;7:226–233.
26. Severino VO, Napimoga MH, de Lima Pereira SA. Expression of IL-6, IL-10, IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitis. Arch Oral Biol 2011;56:823–828.
27. Arikan F, Buduneli N, Lappin DF. C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study. Int J Oral Maxillofac Implants 2011;26:282–289.
28. Melo RF, Lopes BM, Shibli JA, Marcantonio E Jr, Marcantonio RA, Galli GM. Interleukin-1β and interleukin-6 expression and gene polymorphisms in subjects with peri-implant disease. Clin Implant Dent Relat Res 2012;14:905–914.
29. Rakic M, Lekovic V, Nikolic-Jakoba N, Vojvodic D, Petkovic-Curcin A, Sanz M. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. Clin Oral Implants Res 2013;24:1110–1116.
30. Darabi E, Kadkhoda Z, Amirzargar A. Comparison of the levels of tumor necrosis factor-α and interleukin-17 in gingival crevicular fluid of patients with peri-implantitis and a control group with healthy implants. Iran J Allergy Asthma Immunol 2013;12:75–80.
31. Casado PL, Canullo L, de Almeida Filardy A, Granjeiro JM, Barboza EP, Leite Duarte ME. Interleukins 1β and 10 expressions in the periimplant crevicular fluid from patients with untreated periimplant disease. Implant Dent 2013;22:143–150.
32. Rakic M, Struillou X, Petkovic-Curcin A et al. Estimation of bone loss biomarkers as a diagnostic tool for peri-implantitis. J Periodontol 2014;85:1566–1574.
33. Yaghobee S, Khorsand A, Rasouli Ghohroudi AA, Sanjari K, Kadkhodazadeh M. Assessment of interleukin-1beta and interleukin-6 in the crevicular fluid around healthy implants, implants with peri-implantitis, and healthy teeth: a cross-sectional study. J Korean Assoc Oral Maxillofac Surg 2014;40:220–224.
34. Wang HL, Garaicoa-Pazmino C, Collins A, Ong HS, Chudri R, Giannobile WV. Protein biomarkers and microbial profiles in peri-implantitis. Clin Oral Implants Res 2015. doi:10.1111/clr.12708.
35. Ata-Ali J, Flichy-Fernández AJ, Alegre-Domingo T, Ata-Ali F, Palacio J, Peñarrocha-Diago M. Clinical, microbiological, and immunological aspects of healthy vs. peri-implantitis tissue in full arch reconstruction patients: a prospective cross-sectional study. BMC Oral Health 2015;15:43.
36. Zhang Y, Wang C, Jinbu Y, Itoh H, Kusama M. Increased IL-6 levels in peri-implant crevicular fluid correlate with peri-implantitis. Oral Med Pathol 2005;10:95–99.
37. Bryant VL, Slade CA. Chemokines, their receptors and human disease: the good, the bad and the itchy. Immunol Cell Biol 2015;93:364–371.
38. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 2014;14:329–342.
39. Rauner M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol 2007;143:31–48.
40. Zupan J, Jeras M, Marc J. Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem Med (Zagreb) 2013;23:43–63.